Sat Kartar

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0NB801022
  • NSEID: SATKARTAR
  • BSEID:
INR
166.85
-6.15 (-3.55%)
BSENSE

Dec 05

BSE+NSE Vol: 24000

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sat Kartar Shopping Ltd stock-summary
stock-summary
Sat Kartar Shopping Ltd
Micro Cap
Pharmaceuticals & Biotechnology
Sat Kartar Shopping Limited was incorporated as a Private Limited Company with the name of "Sat Kartar Shopping Private Limited" vide Certificate of Incorporation dated June 29, 2012, issued by Registrar of Companies, Delhi. Further, Company converted into a Public Limited Company & name of the Company was changed to Sat Kartar Shopping Limited & Registrar of Companies, Delhi has issued a New Certificate of Incorporation consequent upon conversion dated July 12, 2021.
Company Coordinates stock-summary
Icon
No Company Details Available
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 2 FIIs (0.44%)

Promoter with highest holding

Ajooni Wellness Private Limited (36.28%)

Highest Public shareholder

Shreya Jain (3.56%)

Individual Investors Holdings

24.41%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Material Sold
8.9999
0%
 
100
Cost of Material Sold
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR Cr (Micro Cap)

stock-summary
P/E

28.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

0.00